procarbazine has been researched along with Local Neoplasm Recurrence in 169 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adding temozolomide (TMZ) to radiation for patients with newly-diagnosed anaplastic astrocytomas (AAs) is common clinical practice despite the lack of prospective studies demonstrating a survival advantage." | 9.22 | The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. ( Abuali, I; Grossman, SA; Lu, Y; Strowd, RE; Ye, X, 2016) |
| "The aims of this phase I study in patients with recurrent malignant gliomas were to determine the maximum tolerated dose (MTD) and toxicity profile of fotemustine when combined with a fixed dose of procarbazine (PCZ), and to evaluate the extent of O6-alkylguanine-DNA alkyltransferase (ATase) depletion in circulating lymphocytes during treatment." | 9.09 | Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity. ( Berger, E; Boiardi, A; Ciusani, E; Giroux, B; Lucas, C; Margison, G; Silvani, A; Watson, A, 2001) |
| "Previous investigators have reported responses in 52% of patients treated with mechlorethamine (nitrogen mustard), vincristine, and procarbazine (MOP) for recurrent glioma." | 9.08 | Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. ( Buckner, JC; Burch, PA; Dinapoli, RP; Galanis, E; Mailliard, JA; Morton, RF; Novotny, PJ; Rowland, KM; Schaefer, PL; Scheithauer, BW; Vukov, AM, 1998) |
| "Twenty six (17 males) patients with glioblastoma (GBL), median age 55 years, median Karnofsky Index (KI) 70/100, and 11 patients (9 males) with anaplastic astrocytoma (AA), median age 56 years, median KI 70/100 were treated at recurrence with dibromodulcitol (DBD) 1400 mg/m2 on day 1, BCNU 150 mg/m2 on day 2, and procarbazine (PCZ) 150 mg/day on days 1 to 15." | 9.08 | Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study. ( De Witte, O; Hildebrand, J; Sahmoud, T, 1998) |
| "Paclitaxel demonstrated modest efficacy with minimal toxicity in this pretreated cohort of adult patients with recurrent hemispheric oligodendrogliomas." | 9.08 | Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas. ( Chamberlain, MC; Kormanik, PA, 1997) |
| "Twenty patients previously treated with surgery, radiation therapy and chemotherapy with a nitrosourea for malignant supratentorial gliomas received a combination of procarbazine, thiotepa and vincristine (P." | 9.07 | Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study. ( Ameri, A; Chen, QM; Delattre, JY; Poisson, M, 1993) |
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 9.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "To assess the effectiveness and safety of procarbazine, lomustine, and vincristine (PCV) chemotherapy with other interventions in adults with recurrent high-grade glioma." | 8.95 | Procarbazine, lomustine and vincristine for recurrent high-grade glioma. ( Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL, 2017) |
| " Here we describe the occurrence of pseudoprogression in patients with anaplastic oligodendrogliomas treated with postoperative procarbazine, lomustine and vincristine (PCV) chemotherapy alone." | 8.31 | T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone. ( Boutet, C; Carpentier, C; Dehais, C; Di Stefano, AL; Ducray, F; Esparragosa Vazquez, I; Figarella-Branger, D; Forest, F; Larrieu-Ciron, D; Meyronet, D; Ndiaye, M; Picart, T; Rivoirard, R; Seyve, A; Vassal, F; Younan, N, 2023) |
| "Systematic evaluation of the effectiveness and safety of combined procarbazine, lomustine, and vincristine for treating recurrent high-grade glioma." | 7.96 | A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis. ( Cai, Y; Jiang, YG; Jiang, ZH; Tan, ZG; Wang, M, 2020) |
| "Effective chemotherapy using PCV (procarbazine, lomustine and vincristine) has been documented in anaplastic oligodendrogliomas and oligoastrocytomas." | 7.69 | [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma]. ( Bouffet, E; Bret, P; Helfre, S; Jouvet, A; Mertens, P; Mornex, F; Sindou, M; Thiesse, P, 1997) |
| "Our results indicate that chemotherapy with a combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea is active for patients with recurrent anaplastic gliomas and glioblastomas not previously treated with nitrosourea-based chemotherapy but is inactive for patients with glioblastomas previously treated with chemotherapy." | 7.69 | Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. ( Bruner, J; Flowers, A; Gleason, MJ; Ictech, SE; Jaeckle, KA; Kyritsis, AP; Levin, VA; Yung, WK, 1996) |
| "Forty-seven patients with medulloblastoma were treated postoperatively with procarbazine, followed by craniospinal radiation therapy in combination with hydroxyurea." | 7.67 | Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. ( Davis, RL; Edwards, MS; Fulton, D; Levin, VA; Liu, HC; Rodriguez, LA; Silver, P; Wara, W; Wilson, CB, 1988) |
| "Seventeen patients with recurrent medulloblastoma were treated with a combination of three drugs: procarbazine, CCNU, and vincristine (PCV)." | 7.66 | Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. ( Crafts, DC; Edwards, MS; Levin, VA; Pischer, TL; Wilson, CB, 1978) |
| "2 cases of recurrent medulloblastomas are described who both responded to vincristine alone and in combination with procarbazine." | 7.66 | Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases. ( Fricker, U; Reichenbach, W; Seiler, RW; Wagner, HP, 1978) |
| " PCB was administered as an oral dosage of 450 mg on days 1-2 and a total dose of 300 mg on day 3." | 6.73 | Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients. ( Boiardi, A; Botturi, A; Eoli, M; Falcone, C; Filippini, G; Fiumani, A; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A, 2008) |
| "Temozolomide was in general well tolerated; the most frequent side-effects were hematological." | 6.71 | Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. ( Baron, B; Boogerd, W; Bravo Marques, J; Chinot, O; De Beule, N; Kros, JM; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, CJ, 2003) |
| "Adding temozolomide (TMZ) to radiation for patients with newly-diagnosed anaplastic astrocytomas (AAs) is common clinical practice despite the lack of prospective studies demonstrating a survival advantage." | 5.22 | The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. ( Abuali, I; Grossman, SA; Lu, Y; Strowd, RE; Ye, X, 2016) |
| "Twenty-three patients with recurrent or progressive oligodendrogliomas or oligoastrocytomas after first-line PCV (procarbazine, lomustine, and vincristine) chemotherapy were enrolled in a single-institution Phase II study of second-line carboplatin chemotherapy." | 5.11 | Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study. ( Borgognone, M; Costanza, A; Laguzzi, E; Mutani, R; Nobile, M; Rudà, R; Soffietti, R, 2004) |
| "The aim of this study was to compare tolerance of a nitrosurea-based regime with 'standard' therapy of vincristine (VCR) and carboplatin for low-grade gliomas." | 5.10 | Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas. ( Hoddes, JA; Lancaster, DL; Michalski, A, 2003) |
| "The aims of this phase I study in patients with recurrent malignant gliomas were to determine the maximum tolerated dose (MTD) and toxicity profile of fotemustine when combined with a fixed dose of procarbazine (PCZ), and to evaluate the extent of O6-alkylguanine-DNA alkyltransferase (ATase) depletion in circulating lymphocytes during treatment." | 5.09 | Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity. ( Berger, E; Boiardi, A; Ciusani, E; Giroux, B; Lucas, C; Margison, G; Silvani, A; Watson, A, 2001) |
| " Between May 1992 and January 1998, eight children with unresectable or recurrent intramedullary glioma were treated with the BB SFOP protocol (a 16-month chemotherapy regimen with carboplatin, procarbazine, vincristine, cyclophosphamide, etoposide and cisplatin)." | 5.09 | Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP). ( Chastagner, P; Chouffai, Z; Couanet, D; Doireau, V; Grignon, Y; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Marchal, JC; Zerah, M, 1999) |
| "Previous investigators have reported responses in 52% of patients treated with mechlorethamine (nitrogen mustard), vincristine, and procarbazine (MOP) for recurrent glioma." | 5.08 | Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. ( Buckner, JC; Burch, PA; Dinapoli, RP; Galanis, E; Mailliard, JA; Morton, RF; Novotny, PJ; Rowland, KM; Schaefer, PL; Scheithauer, BW; Vukov, AM, 1998) |
| "Twenty six (17 males) patients with glioblastoma (GBL), median age 55 years, median Karnofsky Index (KI) 70/100, and 11 patients (9 males) with anaplastic astrocytoma (AA), median age 56 years, median KI 70/100 were treated at recurrence with dibromodulcitol (DBD) 1400 mg/m2 on day 1, BCNU 150 mg/m2 on day 2, and procarbazine (PCZ) 150 mg/day on days 1 to 15." | 5.08 | Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study. ( De Witte, O; Hildebrand, J; Sahmoud, T, 1998) |
| "Paclitaxel demonstrated modest efficacy with minimal toxicity in this pretreated cohort of adult patients with recurrent hemispheric oligodendrogliomas." | 5.08 | Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas. ( Chamberlain, MC; Kormanik, PA, 1997) |
| "Twenty patients previously treated with surgery, radiation therapy and chemotherapy with a nitrosourea for malignant supratentorial gliomas received a combination of procarbazine, thiotepa and vincristine (P." | 5.07 | Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study. ( Ameri, A; Chen, QM; Delattre, JY; Poisson, M, 1993) |
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 5.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "To assess the effectiveness and safety of procarbazine, lomustine, and vincristine (PCV) chemotherapy with other interventions in adults with recurrent high-grade glioma." | 4.95 | Procarbazine, lomustine and vincristine for recurrent high-grade glioma. ( Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL, 2017) |
| " Here we describe the occurrence of pseudoprogression in patients with anaplastic oligodendrogliomas treated with postoperative procarbazine, lomustine and vincristine (PCV) chemotherapy alone." | 4.31 | T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone. ( Boutet, C; Carpentier, C; Dehais, C; Di Stefano, AL; Ducray, F; Esparragosa Vazquez, I; Figarella-Branger, D; Forest, F; Larrieu-Ciron, D; Meyronet, D; Ndiaye, M; Picart, T; Rivoirard, R; Seyve, A; Vassal, F; Younan, N, 2023) |
| "Systematic evaluation of the effectiveness and safety of combined procarbazine, lomustine, and vincristine for treating recurrent high-grade glioma." | 3.96 | A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis. ( Cai, Y; Jiang, YG; Jiang, ZH; Tan, ZG; Wang, M, 2020) |
| "The authors evaluated response, time to progression (TTP), survival, prognostic factors, and toxicity in 63 patients with a recurrent glioblastoma multiforme treated with procarbazine, lomustine, and vincristine (PCV) chemotherapy." | 3.71 | PCV chemotherapy for recurrent glioblastoma multiforme. ( Groeneveld, GJ; Heimans, JJ; Kappelle, AC; Postma, TJ; Sneeuw, KC; Taphoorn, MJ; van den Bent, MJ; van Groeningen, CJ; Zonnenberg, BA, 2001) |
| "We treated 54 patients, newly diagnosed for glioblastoma, with systemic chemotherapy (carmustine (BCNU) 100 mg/m2 and cisplatin 90 mg/m2 every 6 weeks) and radiotherapy soon after surgery." | 3.70 | Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients. ( Boiardi, A; Broggi, G; Eoli, M; Pozzi, A; Salmaggi, A; Silvani, A, 1999) |
| "Effective chemotherapy using PCV (procarbazine, lomustine and vincristine) has been documented in anaplastic oligodendrogliomas and oligoastrocytomas." | 3.69 | [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma]. ( Bouffet, E; Bret, P; Helfre, S; Jouvet, A; Mertens, P; Mornex, F; Sindou, M; Thiesse, P, 1997) |
| "Our results indicate that chemotherapy with a combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea is active for patients with recurrent anaplastic gliomas and glioblastomas not previously treated with nitrosourea-based chemotherapy but is inactive for patients with glioblastomas previously treated with chemotherapy." | 3.69 | Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. ( Bruner, J; Flowers, A; Gleason, MJ; Ictech, SE; Jaeckle, KA; Kyritsis, AP; Levin, VA; Yung, WK, 1996) |
| " The drug combination vincristine, procarbazine, and dibromdulcitol proved to be effective in a pilot trial on relapsed medulloblastomas: 8 complete and 4 partial remissions were achieved from 16 cases." | 3.68 | Treatment of malignant scala posterior brain tumors in children: the chemotherapy of relapsed medulloblastoma with a dibromdulcitol containing drug regime and pharmacokinetic studies of dibromdulcitol in children. ( Kálmánchey, R; Koóos, R; Paraicz, E; Schuler, D; Somló, P, 1992) |
| "Forty-seven patients with medulloblastoma were treated postoperatively with procarbazine, followed by craniospinal radiation therapy in combination with hydroxyurea." | 3.67 | Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. ( Davis, RL; Edwards, MS; Fulton, D; Levin, VA; Liu, HC; Rodriguez, LA; Silver, P; Wara, W; Wilson, CB, 1988) |
| "Combination chemotherapy consisting of cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) was administered to 5 patients with invasive lymphoepithelial thymoma." | 3.66 | Combination chemotherapy in invasive thymoma role of COPP. ( Evans, WK; Feld, R; Phillips, MJ; Simpson, WJ; Thompson, DM, 1980) |
| "2 cases of recurrent medulloblastomas are described who both responded to vincristine alone and in combination with procarbazine." | 3.66 | Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases. ( Fricker, U; Reichenbach, W; Seiler, RW; Wagner, HP, 1978) |
| "Seventeen patients with recurrent medulloblastoma were treated with a combination of three drugs: procarbazine, CCNU, and vincristine (PCV)." | 3.66 | Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. ( Crafts, DC; Edwards, MS; Levin, VA; Pischer, TL; Wilson, CB, 1978) |
| "Primary intraocular lymphoma is a rare variant of primary CNS lymphoma for which the optimum treatment strategy remains unknown." | 2.82 | Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. ( Cheah, CY; Chihara, D; Dabaja, BS; Fowler, NH; Gombos, DS; Milgrom, S; Pinnix, CC, 2016) |
| " PCB was administered as an oral dosage of 450 mg on days 1-2 and a total dose of 300 mg on day 3." | 2.73 | Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients. ( Boiardi, A; Botturi, A; Eoli, M; Falcone, C; Filippini, G; Fiumani, A; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A, 2008) |
| "Temozolomide was in general well tolerated; the most frequent side-effects were hematological." | 2.71 | Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. ( Baron, B; Boogerd, W; Bravo Marques, J; Chinot, O; De Beule, N; Kros, JM; Taphoorn, MJ; van den Bent, MJ; van der Rijt, CC; Vecht, CJ, 2003) |
| "Seventy-nine patients harboring recurrent brain tumors received four cycles of infraophthalmic carotid injections of 160 mg of carmustine." | 2.67 | Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. ( Hager, B; Hannisdal, E; Hirschberg, H; Nome, O; Watne, K, 1992) |
| "Of 2238 patients with Hodgkin's disease, 91 (4%) were < or = 10 years of age." | 2.67 | Hodgkin's disease in the very young. ( Cleary, SF; Donaldson, SS; Link, MP, 1994) |
| "Thirty seven Hodgkin's lymphoma patients with recurrence after first remission induced by radiation therapy and/or chemotherapy with mustine, oncovin, procarbazine and prednisolone (MOPP) were randomised to treat with a new combination chemotherapy comprising of doxorubicin, oncovin, procarbazine and prednisolone (DOPP)." | 2.65 | A new combination chemotherapy for recurrent Hodgkin's lymphoma. ( Ahmed, Q; Rahim, MA; Sarma, SK, 1982) |
| "Procarbazine was not given as a specified protocol, but for patients who were ineligible or refused other protocols." | 2.38 | Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. ( Levin, VA; Prados, M; Rodriguez, LA; Silver, P, 1989) |
| "Ependymomas represent 10% of pediatric brain tumors." | 1.43 | [Pediatric ependymomas: Current diagnosis and therapy]. ( Alapetite, C; Beuriat, PA; Faure-Conter, C; Frappaz, D; Grill, J; Szathmari, A; Vasiljevic, A, 2016) |
| "These results indicate that the Rituximab combined with second line regimen is an effective therapy for relapsed and refractory Hodgkin lymphoma." | 1.42 | [Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients]. ( Li, H; Liu, H; Qiu, L; Xiong, W; Yi, S; Zou, D, 2015) |
| "Differences between Hodgkin's lymphoma (HL) patients in China and Western countries are known to exist, but data on Chinese patients with HL are limited." | 1.38 | Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites. ( Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ, 2012) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "Cure rates of Hodgkin's disease (HD) with chemotherapy and/or radiotherapy are high." | 1.34 | [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. ( Al-Ali, HK; Niederwieser, D; Wittekind, C, 2007) |
| "Visual impairment was detected in 14 pts (24%), associated with recurrence (p = ." | 1.32 | Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap. ( Jereb, B; Macedoni-Luksic, M; Todorovski, L, 2003) |
| "Esthesioneuroblastomas are radiocurable tumors." | 1.31 | Radiotherapy of esthesioneuroblastoma. ( Eich, HT; Eich, PD; Micke, O; Müller, R; Staar, S; Stützer, H, 2001) |
| "Patients with neurofibromatosis type 1 (NF1) often have gliomas as a complication, most of which are benign pilocytic astrocytomas which have arisen in optic pathways." | 1.31 | Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression. ( Hirato, J; Kamiya, M; Kurachi, H; Nakazato, Y; Sasaki, A; Yokoo, H, 2001) |
| " Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities." | 1.31 | A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. ( Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K, 2001) |
| "Sixteen patients with Hodgkin's disease were treated with MOPP/ABVD and filgrastim support between January 1992 and March 1994." | 1.30 | G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. ( Gustavsson, A, 1997) |
| "Optimal treatment for Hodgkin's disease during childhood is unknown." | 1.30 | Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. ( Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS, 1999) |
| "20 patients in early stages (I-IIB) Hodgkin's disease were treated with smaller than commonly used doses of cytostatics and radiation." | 1.29 | [Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease]. ( Dubowik, R; Gabryś, K; Urbaniak-Kujda, D, 1996) |
| "Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease." | 1.29 | Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994) |
| "In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival." | 1.29 | Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995) |
| "Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)." | 1.28 | Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| "Thymic hyperplasia is a poorly understood, apparently benign process that may be confused with recurrent lymphoma." | 1.27 | Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. ( Edington, H; Longo, DL; Pass, H; Roth, JA; Salwitz, J, 1986) |
| "Patients with diffuse histiocytic lymphoma who achieved a histologically proven complete remission after 6 months of treatment without maintenance have remained disease-free whereas those with nodular poorly differentiated lymphocytic and diffuse well-differentiated lymphocytic lymphomas have demonstrated a pattern of continuous late recurrence." | 1.25 | Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. ( Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (33.73) | 18.7374 |
| 1990's | 49 (28.99) | 18.2507 |
| 2000's | 36 (21.30) | 29.6817 |
| 2010's | 23 (13.61) | 24.3611 |
| 2020's | 4 (2.37) | 2.80 |
| Authors | Studies |
|---|---|
| Lian, K | 3 |
| Zhang, QH | 3 |
| Hou, SL | 3 |
| Li, L | 3 |
| Esparragosa Vazquez, I | 1 |
| Ndiaye, M | 1 |
| Di Stefano, AL | 1 |
| Younan, N | 1 |
| Larrieu-Ciron, D | 1 |
| Seyve, A | 1 |
| Picart, T | 1 |
| Meyronet, D | 1 |
| Boutet, C | 1 |
| Vassal, F | 1 |
| Carpentier, C | 1 |
| Figarella-Branger, D | 1 |
| Dehais, C | 1 |
| Forest, F | 1 |
| Rivoirard, R | 1 |
| Ducray, F | 2 |
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Cai, Y | 1 |
| Jiang, YG | 1 |
| Wang, M | 1 |
| Jiang, ZH | 1 |
| Tan, ZG | 1 |
| Parasramka, S | 1 |
| Talari, G | 1 |
| Rosenfeld, M | 1 |
| Guo, J | 1 |
| Villano, JL | 1 |
| Klimova, A | 1 |
| Heissigerova, J | 1 |
| Rihova, E | 1 |
| Brichova, M | 1 |
| Pytlik, R | 1 |
| Spicka, I | 1 |
| Mrazova, K | 1 |
| Karolova, J | 1 |
| Svozilkova, P | 1 |
| Ansell, SM | 1 |
| Danielewicz, I | 1 |
| Małkowski, B | 1 |
| Zaucha, R | 1 |
| Zalewska, M | 1 |
| Leśniewski-Kmak, K | 1 |
| Zaucha, JM | 1 |
| Raemaekers, JM | 1 |
| André, MP | 1 |
| Federico, M | 1 |
| Girinsky, T | 1 |
| Oumedaly, R | 1 |
| Brusamolino, E | 1 |
| Brice, P | 1 |
| Fermé, C | 1 |
| van der Maazen, R | 1 |
| Gotti, M | 1 |
| Bouabdallah, R | 1 |
| Sebban, CJ | 1 |
| Lievens, Y | 1 |
| Re, A | 1 |
| Stamatoullas, A | 1 |
| Morschhauser, F | 1 |
| Lugtenburg, PJ | 1 |
| Abruzzese, E | 1 |
| Olivier, P | 1 |
| Casasnovas, RO | 1 |
| van Imhoff, G | 1 |
| Raveloarivahy, T | 1 |
| Bellei, M | 1 |
| van der Borght, T | 1 |
| Bardet, S | 1 |
| Versari, A | 1 |
| Hutchings, M | 1 |
| Meignan, M | 1 |
| Fortpied, C | 1 |
| Nagai, H | 1 |
| Belada, D | 1 |
| Štěpánková, P | 1 |
| Sýkorová, A | 1 |
| Žák, P | 1 |
| Smolej, L | 1 |
| Brämswig, JH | 1 |
| Riepenhausen, M | 1 |
| Schellong, G | 1 |
| Carvalho, BF | 1 |
| Fernandes, AC | 1 |
| Almeida, DS | 1 |
| Sampaio, LV | 1 |
| Costa, A | 1 |
| Caeiro, C | 1 |
| Osório, L | 1 |
| Castro, L | 1 |
| Linhares, P | 1 |
| Damasceno, M | 1 |
| Vaz, RC | 1 |
| Liu, H | 1 |
| Li, H | 1 |
| Xiong, W | 1 |
| Yi, S | 1 |
| Zou, D | 1 |
| Qiu, L | 1 |
| Cheah, CY | 1 |
| Milgrom, S | 1 |
| Chihara, D | 1 |
| Gombos, DS | 1 |
| Pinnix, CC | 1 |
| Dabaja, BS | 1 |
| Fowler, NH | 1 |
| Strowd, RE | 1 |
| Abuali, I | 1 |
| Ye, X | 1 |
| Lu, Y | 1 |
| Grossman, SA | 1 |
| Avagyan, A | 1 |
| Danielyan, S | 1 |
| Voskanyan, A | 1 |
| Sargsyan, L | 1 |
| Hakobyan, L | 1 |
| Zohrabyan, D | 1 |
| Safaryan, L | 1 |
| Harutyunyan, L | 1 |
| Bardakchyan, S | 1 |
| Iskanyan, S | 1 |
| Arakelyan, S | 1 |
| Tamamyan, G | 1 |
| Frappaz, D | 3 |
| Vasiljevic, A | 1 |
| Beuriat, PA | 1 |
| Alapetite, C | 1 |
| Grill, J | 3 |
| Szathmari, A | 1 |
| Faure-Conter, C | 1 |
| Baumert, BG | 1 |
| Stupp, R | 1 |
| Niu, Y | 1 |
| Shi, YK | 1 |
| He, XH | 1 |
| Feng, FY | 1 |
| Zhou, LQ | 2 |
| Gu, DZ | 1 |
| Agha, CA | 1 |
| Ibrahim, S | 1 |
| Hassan, A | 1 |
| Elias, DA | 1 |
| Fathallah-Shaykh, HM | 1 |
| Ferreri, AJ | 1 |
| Verona, C | 1 |
| Politi, LS | 1 |
| Chiara, A | 1 |
| Perna, L | 1 |
| Villa, E | 1 |
| Reni, M | 1 |
| Sierra Del Rio, M | 1 |
| Ricard, D | 1 |
| Houillier, C | 1 |
| Navarro, S | 1 |
| Gonzalez-Aguilar, A | 1 |
| Idbaih, A | 1 |
| Kaloshi, G | 1 |
| Elhallani, S | 1 |
| Omuro, A | 1 |
| Choquet, S | 1 |
| Soussain, C | 1 |
| Hoang-Xuan, K | 1 |
| Bruessow, C | 1 |
| Karrer, U | 1 |
| Gubler, J | 1 |
| Pless, M | 1 |
| Li, ZM | 1 |
| Zhu, YJ | 1 |
| Xia, Y | 1 |
| Huang, JJ | 1 |
| Jiang, WQ | 1 |
| Kuhnhenn, J | 1 |
| Kowalski, T | 1 |
| Steenken, S | 1 |
| Ostermann, K | 1 |
| Schlegel, U | 2 |
| Pizer, B | 1 |
| Salehzadeh, A | 1 |
| Brodbelt, A | 1 |
| Mallucci, C | 1 |
| Afra, D | 1 |
| Sipos, L | 1 |
| Vitanovics, D | 1 |
| Zander, T | 1 |
| Nettekoven, W | 1 |
| Kraus, JA | 1 |
| Pels, H | 2 |
| Ko, YD | 1 |
| Vetter, H | 1 |
| Klockgether, T | 1 |
| Baker, MJ | 1 |
| Brem, S | 1 |
| Daniels, S | 1 |
| Sherman, B | 1 |
| Phuphanich, S | 1 |
| Macedoni-Luksic, M | 1 |
| Jereb, B | 1 |
| Todorovski, L | 1 |
| van den Bent, MJ | 3 |
| Looijenga, LH | 1 |
| Langenberg, K | 1 |
| Dinjens, W | 1 |
| Graveland, W | 1 |
| Uytdewilligen, L | 1 |
| Sillevis Smitt, PA | 1 |
| Jenkins, RB | 1 |
| Kros, JM | 2 |
| Vos, MJ | 1 |
| Uitdehaag, BM | 1 |
| Barkhof, F | 1 |
| Heimans, JJ | 3 |
| Baayen, HC | 1 |
| Boogerd, W | 2 |
| Castelijns, JA | 1 |
| Elkhuizen, PH | 1 |
| Postma, TJ | 3 |
| Chinot, O | 1 |
| Bravo Marques, J | 1 |
| Taphoorn, MJ | 2 |
| van der Rijt, CC | 1 |
| Vecht, CJ | 1 |
| De Beule, N | 1 |
| Baron, B | 1 |
| Sunyach, MP | 1 |
| Pommier, P | 1 |
| Martel Lafay, I | 1 |
| Guyotat, J | 1 |
| Ginestet, G | 1 |
| Jouanneau, E | 1 |
| Jouvet, A | 2 |
| Sindou, M | 2 |
| Bret, P | 2 |
| Carrie, C | 1 |
| Lancaster, DL | 1 |
| Hoddes, JA | 1 |
| Michalski, A | 1 |
| Lichy, MP | 1 |
| Bachert, P | 1 |
| Henze, M | 1 |
| Lichy, CM | 1 |
| Debus, J | 1 |
| Schlemmer, HP | 1 |
| Soffietti, R | 1 |
| Nobile, M | 1 |
| Rudà, R | 1 |
| Borgognone, M | 1 |
| Costanza, A | 1 |
| Laguzzi, E | 1 |
| Mutani, R | 1 |
| Higuchi, Y | 1 |
| Iwadate, Y | 1 |
| Yamaura, A | 1 |
| Herrlinger, U | 2 |
| Hebart, H | 1 |
| Kanz, L | 1 |
| Dichgans, J | 2 |
| Weller, M | 2 |
| Partap, S | 1 |
| Spence, AM | 1 |
| Walker, C | 1 |
| Haylock, B | 1 |
| Husband, D | 1 |
| Joyce, KA | 1 |
| Fildes, D | 1 |
| Jenkinson, MD | 1 |
| Smith, T | 1 |
| Broome, J | 1 |
| Kopitzki, K | 1 |
| du Plessis, DG | 1 |
| Prosser, J | 1 |
| Vinjamuri, S | 1 |
| Warnke, PC | 1 |
| Capra, M | 1 |
| Hewitt, M | 1 |
| Radford, M | 1 |
| Hayward, J | 1 |
| Weston, CL | 1 |
| Machin, D | 1 |
| Silvani, A | 4 |
| Lamperti, E | 1 |
| Gaviani, P | 1 |
| Eoli, M | 2 |
| Fiumani, A | 1 |
| Salmaggi, A | 2 |
| Falcone, C | 1 |
| Filippini, G | 1 |
| Botturi, A | 1 |
| Boiardi, A | 4 |
| Yamanaka, R | 1 |
| Shinbo, Y | 1 |
| Sano, M | 1 |
| Homma, J | 1 |
| Tsuchiya, N | 1 |
| Yajima, N | 1 |
| Tamura, T | 1 |
| Hondoh, H | 1 |
| Takahashi, H | 1 |
| Morii, K | 1 |
| Onda, K | 1 |
| Tanaka, R | 1 |
| Al-Ali, HK | 1 |
| Wittekind, C | 1 |
| Niederwieser, D | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| Gill, P | 1 |
| Litzow, M | 1 |
| Buckner, J | 1 |
| Arndt, C | 1 |
| Moynihan, T | 1 |
| Christianson, T | 1 |
| Ansell, S | 1 |
| Galanis, E | 2 |
| Coleman, M | 1 |
| Martin, P | 1 |
| Ruan, J | 1 |
| Furman, R | 1 |
| Niesvizky, R | 1 |
| Elstrom, R | 1 |
| George, P | 1 |
| Kaufman, TP | 1 |
| Leonard, JP | 1 |
| Klener, P | 1 |
| Donner, L | 1 |
| Gassmann, W | 1 |
| Schmitz, N | 1 |
| Löffler, H | 1 |
| Bartual, J | 1 |
| Roquette, J | 1 |
| Gil, M | 1 |
| Magro, E | 1 |
| Bascuas, JL | 1 |
| Bartels, H | 1 |
| Schneider, B | 1 |
| Feller, AC | 1 |
| Harker, WG | 1 |
| Kushlan, P | 1 |
| Rosenberg, SA | 3 |
| Poplin, EA | 1 |
| Aisner, J | 1 |
| Van Echo, DA | 1 |
| Whitacre, M | 1 |
| Wiernik, PH | 1 |
| Lieberman, AN | 1 |
| Foo, SH | 1 |
| Ransohoff, J | 1 |
| Wise, A | 1 |
| George, A | 1 |
| Gordon, W | 1 |
| Walker, R | 1 |
| Bezwoda, WR | 1 |
| Derman, DP | 1 |
| de Moor, NG | 1 |
| Kallenbach, J | 1 |
| Briancon, S | 1 |
| Thisse, JY | 1 |
| Watrin, H | 1 |
| Feintrenie, X | 1 |
| Lamaze, R | 1 |
| Lamy, P | 1 |
| Schmidt, JD | 1 |
| Scott, WW | 1 |
| Gibbons, R | 1 |
| Johnson, DE | 1 |
| Prout, GR | 1 |
| Loening, S | 1 |
| Soloway, M | 1 |
| deKernion, JB | 1 |
| Pontes, JE | 1 |
| Slack, NH | 1 |
| Murphy, GP | 2 |
| Bremer, AM | 1 |
| Nguyen, TQ | 1 |
| Balsys, R | 1 |
| Baĭsogolov, GD | 4 |
| Shakhtarina, SV | 3 |
| Schmitt, K | 1 |
| Tulzer, W | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Kovalenko, NS | 1 |
| Fokina, NT | 2 |
| Vorob'ev, AI | 1 |
| Brilliant, MD | 1 |
| Fil'kova, EM | 1 |
| Cramer, P | 1 |
| Schaison, G | 1 |
| Andrieu, JM | 2 |
| Boiron, M | 2 |
| Bernard, J | 2 |
| Vialushkin, BIa | 1 |
| Koshel', IV | 1 |
| Tsyplenkov, VG | 1 |
| Isaev, IG | 1 |
| Rahim, MA | 1 |
| Sarma, SK | 1 |
| Ahmed, Q | 1 |
| Gallmeier, WM | 1 |
| Bruntsch, U | 1 |
| Levin, VA | 7 |
| Wilson, CB | 4 |
| Vestnys, PS | 1 |
| Timothy, AR | 1 |
| Sutcliffe, SB | 1 |
| Lister, TA | 1 |
| Wrigley, PF | 1 |
| Jones, AE | 1 |
| Evans, WK | 1 |
| Thompson, DM | 1 |
| Simpson, WJ | 1 |
| Feld, R | 1 |
| Phillips, MJ | 1 |
| Cleary, SF | 1 |
| Link, MP | 2 |
| Donaldson, SS | 2 |
| Fuchs, R | 2 |
| Löffler, M | 2 |
| Pfreundschuh, M | 2 |
| Dölken, G | 2 |
| Gerhartz, H | 2 |
| Hagen-Aukamp, U | 2 |
| Hiller, E | 2 |
| Petsch, S | 2 |
| Pflüger, KH | 2 |
| Rühl, U | 2 |
| Shpilberg, O | 1 |
| Shiff, J | 1 |
| Chetrit, A | 1 |
| Ramot, B | 1 |
| Ben-Bassat, I | 1 |
| Salvagno, L | 1 |
| Sorarù, M | 1 |
| Sotti, G | 1 |
| Aversa, S | 1 |
| Chiarion Sileni, V | 1 |
| Mazzarotto, R | 1 |
| Scarzello, G | 1 |
| Bianco, A | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 2 |
| Lob, S | 1 |
| Bergmann, L | 1 |
| Müller, H | 1 |
| Jacobi, V | 1 |
| Hoelzer, D | 1 |
| Niitsu, N | 1 |
| Kaneko, H | 1 |
| Umeda, M | 1 |
| Shirai, T | 1 |
| Sobol, RE | 1 |
| Fakhrai, H | 1 |
| Shawler, D | 1 |
| Gjerset, R | 1 |
| Dorigo, O | 1 |
| Carson, C | 1 |
| Khaleghi, T | 1 |
| Koziol, J | 1 |
| Shiftan, TA | 1 |
| Royston, I | 1 |
| Cole, SJ | 1 |
| Fraser, DE | 1 |
| Whittle, IR | 1 |
| Cairncross, JG | 4 |
| Hagemeister, FB | 2 |
| Purugganan, R | 1 |
| Fuller, L | 1 |
| McLaughlin, P | 1 |
| Swan, F | 1 |
| Romaguera, J | 1 |
| Rodriguez, M | 1 |
| Cabanillas, F | 2 |
| Fisher, PM | 1 |
| Dodwell, DJ | 1 |
| Bridges, LR | 1 |
| Cartwright, SC | 1 |
| Stone, J | 1 |
| Ameri, A | 1 |
| Poisson, M | 1 |
| Chen, QM | 1 |
| Delattre, JY | 1 |
| Gosselin, M | 1 |
| Podgorsak, EB | 1 |
| Evans, MD | 1 |
| Pla, M | 1 |
| Shenouda, G | 1 |
| Jenkin, D | 1 |
| Greenberg, M | 1 |
| Fitzgerald, A | 1 |
| Forsyth, PA | 1 |
| Kyritsis, AP | 2 |
| Yung, WK | 2 |
| Jaeckle, KA | 2 |
| Bruner, J | 1 |
| Gleason, MJ | 1 |
| Ictech, SE | 1 |
| Flowers, A | 1 |
| Gabryś, K | 1 |
| Urbaniak-Kujda, D | 1 |
| Dubowik, R | 1 |
| Gustavsson, A | 1 |
| Chamberlain, MC | 1 |
| Kormanik, PA | 1 |
| Bouffet, E | 1 |
| Mornex, F | 1 |
| Thiesse, P | 1 |
| Mertens, P | 1 |
| Helfre, S | 1 |
| Hildebrand, J | 1 |
| De Witte, O | 1 |
| Sahmoud, T | 1 |
| van Groeningen, CJ | 2 |
| Witjes, RJ | 1 |
| Weerts, JG | 1 |
| Kralendonk, JH | 1 |
| Silva, MM | 1 |
| Morais, JC | 1 |
| Spector, N | 1 |
| Maceira, J | 1 |
| Sousa, MA | 1 |
| Filgueira, AL | 1 |
| Buckner, JC | 1 |
| Burch, PA | 1 |
| Schaefer, PL | 1 |
| Dinapoli, RP | 1 |
| Novotny, PJ | 1 |
| Scheithauer, BW | 1 |
| Rowland, KM | 1 |
| Vukov, AM | 1 |
| Mailliard, JA | 1 |
| Morton, RF | 1 |
| Arranz, R | 1 |
| Gil-Fernández, JJ | 1 |
| Muñoz, E | 1 |
| Acevedo, A | 1 |
| Sobrino, MP | 1 |
| Fernández-Rañada, JM | 1 |
| Brandes, AA | 1 |
| Ermani, M | 1 |
| Turazzi, S | 1 |
| Scelzi, E | 1 |
| Berti, F | 1 |
| Amistà, P | 1 |
| Rotilio, A | 1 |
| Licata, C | 1 |
| Doireau, V | 1 |
| Zerah, M | 1 |
| Lellouch-Tubiana, A | 1 |
| Couanet, D | 2 |
| Chastagner, P | 2 |
| Marchal, JC | 1 |
| Grignon, Y | 1 |
| Chouffai, Z | 1 |
| Kalifa, C | 2 |
| Lucas, JB | 1 |
| Horwitz, SM | 1 |
| Horning, SJ | 2 |
| Sayegh, A | 1 |
| Wu, HG | 1 |
| Kim, IH | 1 |
| Ha, SW | 1 |
| Park, CI | 1 |
| Bang, YJ | 1 |
| Huh, DS | 1 |
| Muwakkit, S | 1 |
| Geara, F | 1 |
| Nabbout, B | 1 |
| Farah, RA | 1 |
| Shabb, NS | 1 |
| Hajjar, T | 1 |
| Khogali, M | 1 |
| Brugger, W | 1 |
| Bamberg, M | 1 |
| Küker, W | 1 |
| Montoto, S | 1 |
| Camós, M | 1 |
| López-Guillermo, A | 1 |
| Bosch, F | 1 |
| Cervantes, F | 1 |
| Blandé, J | 1 |
| Esteve, J | 1 |
| Cobo, F | 1 |
| Nomdedeu, B | 1 |
| Campo, E | 1 |
| Montserrat, E | 1 |
| Pozzi, A | 1 |
| Broggi, G | 2 |
| Kappelle, AC | 1 |
| Groeneveld, GJ | 1 |
| Zonnenberg, BA | 1 |
| Sneeuw, KC | 1 |
| Eich, HT | 1 |
| Staar, S | 1 |
| Micke, O | 1 |
| Eich, PD | 1 |
| Stützer, H | 1 |
| Müller, R | 1 |
| Le Deley, MC | 1 |
| Gambarelli, D | 1 |
| Raquin, MA | 1 |
| Pierre-Kahn, A | 1 |
| Habrand, JL | 1 |
| Doz, F | 1 |
| Gentet, JC | 1 |
| Edan, C | 1 |
| Cairncross, G | 1 |
| Swinnen, L | 1 |
| Bayer, R | 1 |
| Rosenfeld, S | 1 |
| Salzman, D | 1 |
| Paleologos, N | 1 |
| Kaminer, L | 1 |
| Forsyth, P | 1 |
| Stewart, D | 1 |
| Peterson, K | 1 |
| Hu, W | 1 |
| Macdonald, D | 1 |
| Ramsay, D | 1 |
| Smith, A | 1 |
| Wakabayashi, T | 1 |
| Kajita, Y | 1 |
| Mizuno, M | 1 |
| Nagasaka, T | 1 |
| Yoshida, J | 1 |
| Yokoo, H | 1 |
| Kamiya, M | 1 |
| Sasaki, A | 1 |
| Hirato, J | 1 |
| Nakazato, Y | 1 |
| Kurachi, H | 1 |
| Ciusani, E | 1 |
| Watson, A | 1 |
| Margison, G | 1 |
| Berger, E | 1 |
| Lucas, C | 1 |
| Giroux, B | 1 |
| Hess, KR | 1 |
| Wong, ET | 1 |
| Prados, MD | 1 |
| Weihrauch, MR | 1 |
| Re, D | 1 |
| Scheidhauer, K | 1 |
| Ansén, S | 1 |
| Dietlein, M | 1 |
| Bischoff, S | 1 |
| Bohlen, H | 1 |
| Wolf, J | 1 |
| Schicha, H | 1 |
| Diehl, V | 1 |
| Tesch, H | 1 |
| Cornely, OA | 1 |
| Bethe, U | 1 |
| Seibold, M | 1 |
| Toepelt, K | 1 |
| Soehngen, D | 1 |
| Ritzkowsky, A | 1 |
| Wilder, RB | 1 |
| Schlembach, PJ | 1 |
| Jones, D | 1 |
| Chronowski, GM | 1 |
| Ha, CS | 1 |
| Younes, A | 1 |
| Barista, I | 1 |
| Cox, JD | 1 |
| Jacquillat, C | 2 |
| Banzet, P | 1 |
| Civatte, J | 1 |
| Puissant, A | 1 |
| Cottenot, F | 1 |
| Israel, L | 1 |
| Belaich, S | 1 |
| Chastang, C | 2 |
| Maral, J | 1 |
| Ertel, IJ | 2 |
| Boesel, C | 1 |
| Heiss, WD | 1 |
| Turnheim, M | 1 |
| Mamoli, B | 1 |
| Vinokurov, VL | 1 |
| Vinokurova, NA | 1 |
| Seiler, RW | 1 |
| Reichenbach, W | 1 |
| Fricker, U | 1 |
| Wagner, HP | 1 |
| Horner, RJ | 1 |
| Chaffey, JT | 1 |
| Rosenthal, DS | 1 |
| Moloney, WC | 1 |
| Cangir, A | 2 |
| van Eys, J | 2 |
| Berry, DH | 1 |
| Hvizdala, E | 1 |
| Morgan, SK | 1 |
| Crafts, DC | 1 |
| Edwards, MS | 2 |
| Pischer, TL | 1 |
| Choi, CH | 1 |
| Carey, RW | 1 |
| Weller, SA | 1 |
| Glatstein, E | 1 |
| Kaplan, HS | 1 |
| Schein, PS | 1 |
| Chabner, BA | 1 |
| Canellos, GP | 1 |
| Young, RC | 1 |
| DeVita, VT | 1 |
| Weil, M | 1 |
| Auclerc, G | 1 |
| Desprez-Curely, JP | 1 |
| Garçon, C | 1 |
| Chantalou, JP | 1 |
| Gemon-Auclerc, MF | 1 |
| Delobel, J | 1 |
| Dana, M | 1 |
| Tanzer, J | 1 |
| Teillet, F | 1 |
| Izrael, V | 1 |
| Chelloul, N | 1 |
| Weisgerber, C | 1 |
| De Heaulme, M | 1 |
| Watne, K | 2 |
| Hannisdal, E | 1 |
| Nome, O | 1 |
| Hager, B | 2 |
| Hirschberg, H | 1 |
| Milanesi, I | 1 |
| Fariselli, L | 1 |
| Kharchenko, VP | 1 |
| Pan'shin, GA | 1 |
| Sotnikov, VM | 1 |
| Datsenko, PV | 1 |
| Ang, PT | 1 |
| Hoppe, RT | 1 |
| Oza, AM | 1 |
| Ganesan, TS | 1 |
| Dorreen, M | 1 |
| Johnson, PW | 1 |
| Waxman, J | 1 |
| Gregory, W | 1 |
| Lim, J | 1 |
| Wright, J | 1 |
| Dadiotis, L | 1 |
| Barbounis, V | 1 |
| Schuler, D | 2 |
| Somló, P | 2 |
| Koóos, R | 1 |
| Kálmánchey, R | 1 |
| Paraicz, E | 2 |
| Macdonald, DR | 2 |
| Ramsay, DA | 1 |
| Masuda, N | 1 |
| Fukuoka, M | 1 |
| Takada, M | 1 |
| Negoro, S | 1 |
| Matsui, K | 1 |
| Takifuji, N | 1 |
| Kudoh, S | 1 |
| Kazunobu, I | 1 |
| Nakagawa, K | 1 |
| Kusunoki, Y | 1 |
| Solidoro, A | 1 |
| Payet, C | 1 |
| Sanchez-Lihon, J | 1 |
| Montalbetti, JA | 1 |
| Munker, R | 1 |
| Nathrath, W | 1 |
| Permanetter, W | 1 |
| Gokel, JM | 1 |
| Błasińska-Morawiec, M | 1 |
| Płuzańska, A | 1 |
| Krykowski, E | 1 |
| Robak, T | 1 |
| Mrówka, I | 1 |
| Afanasova, NV | 1 |
| Anderson, H | 1 |
| Crowther, D | 1 |
| Deakin, DP | 1 |
| Ryder, WD | 1 |
| Radford, JA | 1 |
| Newton, HB | 1 |
| Junck, L | 1 |
| Bromberg, J | 1 |
| Page, MA | 1 |
| Greenberg, HS | 1 |
| Coyle, T | 1 |
| Baptista, J | 1 |
| Winfield, J | 1 |
| Clark, K | 1 |
| Poiesz, B | 1 |
| Kirshner, J | 1 |
| Scalzo, A | 1 |
| Newman-Palmer, N | 1 |
| King, R | 1 |
| Graziano, S | 1 |
| Cunningham, D | 1 |
| Hepplestone, A | 1 |
| Gilchrist, NL | 1 |
| Dagg, JH | 1 |
| Evans, IL | 1 |
| Soukop, M | 1 |
| Göldel, N | 1 |
| Böning, L | 1 |
| Fredrik, A | 1 |
| Hölzel, D | 1 |
| Hartenstein, R | 1 |
| Wilmanns, W | 1 |
| Sposto, R | 1 |
| Jenkin, RD | 1 |
| Boesel, CP | 1 |
| Venes, JL | 1 |
| Ortega, JA | 1 |
| Evans, AE | 1 |
| Wara, W | 2 |
| Hammond, D | 1 |
| Rodriguez, LA | 2 |
| Prados, M | 1 |
| Silver, P | 2 |
| Kretschmar, CS | 1 |
| Tarbell, NJ | 1 |
| Kupsky, W | 1 |
| Lavally, BL | 1 |
| Loeffler, JS | 1 |
| Wolfe, L | 1 |
| Strand, R | 1 |
| Scott, RM | 1 |
| Sallan, SE | 1 |
| Koza, I | 1 |
| Bohunický, L | 1 |
| Svancárová, L | 1 |
| Mardiak, J | 1 |
| Gyárfás, J | 1 |
| Cerný, V | 1 |
| Friedman, HS | 1 |
| Schold, SC | 1 |
| Djang, WT | 1 |
| Kurtzberg, J | 1 |
| Longee, DC | 1 |
| Halperin, EC | 1 |
| Falletta, JM | 1 |
| Coleman, RE | 1 |
| Oakes, WJ | 1 |
| Colonna, P | 1 |
| Kubisz, P | 1 |
| Malou, M | 1 |
| Zouaoui, Z | 1 |
| Abad, MT | 1 |
| Touhami, M | 1 |
| Faid, L | 1 |
| Pendergrass, TW | 1 |
| Milstein, JM | 1 |
| Geyer, JR | 1 |
| Mulne, AF | 1 |
| Kosnik, EJ | 1 |
| Morris, JD | 1 |
| Heideman, RL | 1 |
| Ruymann, FB | 1 |
| Stuntz, JT | 1 |
| Bleyer, WA | 1 |
| Borsi, J | 1 |
| Révész, T | 1 |
| Kardos, G | 1 |
| Koós, R | 1 |
| Liu, HC | 1 |
| Fulton, D | 1 |
| Davis, RL | 1 |
| Pavlov, VV | 1 |
| Willett, CG | 1 |
| Linggood, RM | 1 |
| Leong, JC | 1 |
| Miketic, LM | 1 |
| Stracher, MA | 1 |
| Skates, SJ | 1 |
| Kushner, DC | 1 |
| Baram, TZ | 1 |
| Bruner, JM | 1 |
| Martinez-Prieto, J | 1 |
| Larraín, C | 1 |
| Cuchacovich, M | 1 |
| Conte, G | 1 |
| Edington, H | 1 |
| Salwitz, J | 1 |
| Longo, DL | 1 |
| Roth, JA | 1 |
| Pass, H | 1 |
| Hamlin, JA | 1 |
| Kagan, AR | 1 |
| Friedman, NB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The H10 EORTC/GELA/IIL Randomized Intergroup Trial on Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients With Supradiaphragmatic Stage I/II Hodgkin's Lymphoma[NCT00433433] | Phase 3 | 1,952 participants (Actual) | Interventional | 2006-10-31 | Active, not recruiting | ||
| Second Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy[NCT00003304] | Phase 2 | 29 participants (Anticipated) | Interventional | 1998-04-30 | Completed | ||
| A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas[NCT01445119] | Phase 1 | 58 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma :a Phase II, Single-arm, Open-label, Muti-center Study[NCT02879526] | Phase 2 | 45 participants (Anticipated) | Interventional | 2016-08-31 | Recruiting | ||
| A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme[NCT00088400] | Phase 3 | 30 participants | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for procarbazine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Dis | 2017 |
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2014 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B | 2014 |
Chemotherapy for diffuse low-grade gliomas in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Chemother | 2011 |
Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Damage, Chronic; Brain Injuries | 2003 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 1982 |
[Elderly non-Hodgkin's lymphoma arising in left brachial soft tissue].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Combined Modality Therapy; Cyc | 1993 |
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Ad | 1994 |
Chemotherapy for malignant gliomas.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, D | 1996 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
Aggressive oligodendroglioma: a chemosensitive tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Crani | 1992 |
Redevelopment of small-cell lung cancer nine years after the start of therapy. A case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma, Small Cell; Combined | 1991 |
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Glioblastoma; Glioma; Hum | 1989 |
38 trials available for procarbazine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherap | 2014 |
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cr | 2016 |
The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Dacarbazin | 2016 |
[Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astr | 2002 |
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 2003 |
Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Chi | 2003 |
Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; | 2004 |
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-F | 2008 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combi | 2007 |
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Respons | 2008 |
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.
Topics: Antineoplastic Agents; Brain Neoplasms; California; Carmustine; Clinical Trials as Topic; Drug Thera | 1981 |
The management of stage IIIA Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1980 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1994 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1994 |
Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Glioma; Humans; Male; Middle Ag | 1993 |
Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas.
Topics: Adult; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; | 1997 |
Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Female; Glioblastoma; H | 1998 |
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Female; Glioma; | 1998 |
Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain; Brain N | 1999 |
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Chemotherapy, Adjuvant; Ch | 1999 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous | 1999 |
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Huma | 2000 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant | 2001 |
Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Lymphocytes; Male; Midd | 2001 |
Response and progression in recurrent malignant glioma.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Alitretinoin; Antineoplastic Combine | 1999 |
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas | 2002 |
[Chemotherapy of advanced prostate cancer].
Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Drug Eval | 1977 |
[Therapeutic effect of natulan in a recurrence of a granulosa theca cell tumor of the ovaries (1 case)].
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Middle Aged; N | 1979 |
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1992 |
Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma | 1992 |
Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Glioblastoma; Huma | 1992 |
The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Combined Modality Therapy; Follow-Up | 1992 |
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1991 |
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1991 |
Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; G | 1990 |
The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chi | 1989 |
118 other studies available for procarbazine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Magnetic Resonan | 2023 |
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioma; Humans; | 2020 |
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Eye Neoplasms; Female; | 2018 |
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 2014 |
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose | 2015 |
Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study.
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Ho | 2015 |
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothe | 2015 |
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cycl | 2015 |
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Beva | 2015 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combine | 2016 |
[Pediatric ependymomas: Current diagnosis and therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Ependymoma; Humans; Infant; | 2016 |
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine | 2008 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
Bevacizumab is active as a single agent against recurrent malignant gliomas.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2010 |
Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System | 2011 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2012 |
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; | 2012 |
Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; | 2012 |
Prolonged survival associated with the use of intraoperative carmustine (Gliadel) in a paediatric patient with recurrent grade III astrocytoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Carmustine; Combi | 2013 |
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Female | 2002 |
Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Femal | 2002 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; B | 2003 |
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosome Aberrations; Chromosomes | 2003 |
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplat | 2003 |
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms; | 2004 |
Treatment of low-grade oligodendroglial tumors without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Combined Modal | 2004 |
Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Mo | 2005 |
Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Central Nervous System Neop | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, | 2006 |
Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; D | 2007 |
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; | 2008 |
Therapy of non-Hodgkin's lymphomas in relapse.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Imidazoles; Lymphoma; Neoplasm Recurrence, Loca | 1980 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
[Clinical aspects and therapy of anaplastic T-zone lymphoma].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; | 1984 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Therapy | 1982 |
Long term survival among patients with malignant brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Female; Glioblastoma; Humans; M | 1982 |
Treatment of small cell lung cancer: intensive remission induction, radiation therapy, and maintenance chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therap | 1982 |
[Triple biphasic chemotherapy in the treatment of small-cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Small Cell; Combined | 1983 |
Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Topics: Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Drug Evaluation; Drug Ther | 1980 |
Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Craniopharyngiom | 1984 |
[3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1984 |
[Second tumor following Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Recurrences in lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe | 1983 |
[Combined therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The | 1981 |
[Hodgkin's disease in childhood: long term results].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C | 1982 |
[Treatment procedure in generalized lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1982 |
[3-Year results of the combined (polychemo- and radio-) therapy of stage IIIB-IV lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Hodgkin | 1982 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
Combination chemotherapy in invasive thymoma role of COPP.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Co | 1980 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
[Pleomorphic T-cell lymphoma. The diagnostic problems, therapeutic possibilities and infection-induced complications].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Cy | 1993 |
Interleukin-2 gene therapy in a patient with glioblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cells, Cultured; Combined Modality | 1995 |
Rapid resolution following chemotherapy of Broca's dysphasia due to recurrent anaplastic astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aphasia, Broca; Astrocytoma; Fatal Outcome; Follow-U | 1994 |
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1993 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Pr | 1996 |
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1996 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
[Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Gl | 1997 |
Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 1998 |
Lymphomatoid papulosis followed by Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hodg | 1998 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1999 |
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylati | 2000 |
Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Chemotherapy | 1999 |
PCV chemotherapy for recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Glioblasto | 2001 |
Radiotherapy of esthesioneuroblastoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Da | 2001 |
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplanta | 2000 |
Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Chemotherapy, A | 2001 |
Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.
Topics: Adolescent; Antigens, Nuclear; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biomarke | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2001 |
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo | 2001 |
Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bacterial Vaccines; BCG Vaccine; Dacarbazine; Drug | 1978 |
Brain tumors in children.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Diagnosis, Differential; Ependymoma; Female; | 1978 |
Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Meth | 1978 |
Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases.
Topics: Brain; Brain Neoplasms; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Med | 1978 |
Relapse of Hodgkin disease after extended-field radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym | 1978 |
Combination chemotherapy with MOPP in children with recurrent brain tumors.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combinati | 1978 |
Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Humans; Lomu | 1978 |
Small cell anaplastic carcinoma of lung. Reappraisal of current management.
Topics: Adult; Aged; Carcinoma; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplas | 1976 |
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo | 1976 |
Nitrosourea chemotherapy for primary malignant gliomas.
Topics: Brain Neoplasms; Carmustine; Drug Therapy, Combination; Fluorouracil; Glioma; Humans; Lomustine; Neo | 1976 |
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymph Nodes | 1975 |
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
[An expanded radical program of radiation therapy with prophylactic irradiation of the lungs in lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1992 |
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl | 1992 |
Treatment of malignant scala posterior brain tumors in children: the chemotherapy of relapsed medulloblastoma with a dibromdulcitol containing drug regime and pharmacokinetic studies of dibromdulcitol in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Pres | 1992 |
Gastric lymphomas: chemotherapy as a primary treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1990 |
[Lennert's lymphoma and glomerulonephritis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential | 1991 |
[The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hodgkin | 1991 |
Chemotherapy for oligodendroglioma. Progress report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Neoplasm Recurre | 1991 |
Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Drug Eval | 1990 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1987 |
Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality | 1989 |
Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Pres | 1989 |
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Cohort S | 1989 |
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up | 1986 |
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Comb | 1987 |
New drug combination for the treatment of relapsed brain tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool | 1988 |
Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain; Cerebellar Neoplasms; Child; Comb | 1988 |
[Course of lymphogranulomatosis with primary location below the diaphragm].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diaphragm; Female; Hodgkin | 1988 |
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship | 1988 |
Salvage chemotherapy for recurrent primary brain tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chi | 1988 |
[Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Female; Humans; Infusio | 1987 |
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease | 1986 |
Lymphomas of the testicle.
Topics: Adult; Aged; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Large B-Cel | 1972 |